The Bio/Pharma Beat

    View Author June 2020

    May 2020 was a light month in non-COVID patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. The two decisions highlighted in this month’s issue of our newsletter are the most significant.